Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:ABBV
AbbVie
|
166.42 | -23,06% | -12,89% | 293.875,72 | 3,73% | 7,03% |
|
NYSE:VZ
Verizon Communications
|
40.06 | 26,19% | 35,58% | 168.622,75 | 6,64% | 0% |
|
NasdaqGS:AMGN
Amgen
|
312.47 | -12,26% | -3,47% | 167.619,75 | 2,88% | 5,31% |
|
NYSE:PFE
Pfizer
|
28.64 | 8,42% | 38,65% | 162.291,22 | 5,87% | -9,31% |
|
NasdaqGS:CMCSA
Comcast Corp
|
39.27 | 46,67% | 62,2% | 154.080,79 | 3,16% | 9,31% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.03 | 61,74% | 72,08% | 89.253,22 | 5,45% | 13,54% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.72 | 20,9% | 30,15% | 84.363,86 | 4,55% | 0,15% |
|
TSE:4519
Chugai Pharmaceutical
|
5007.00 | 0% | 0% | 8.238.086,97 | 1,64% | 0% |
|
TSE:2914
Japan Tobacco
|
4411.00 | 0% | 0% | 7.831.031,96 | 4,4% | 0% |
|
SWX:ALC
Alcon
|
80.08 | 9,95% | 25,4% | 39.591,55 | 0,3% | 8,65% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4130.00 | 0% | 0% | 6.479.696,8 | 4,75% | 0% |
|
NasdaqGS:BIIB
Biogen
|
230.57 | -15,23% | -0,18% | 33.570,28 | 0% | -10,89% |
|
NasdaqGS:BGNE
BeiGene
|
172.85 | 0% | 0% | 18.076,45 | 0% | 0% |
|
NYSE:CE
Celanese
|
157.34 | -14,91% | 4,47% | 17.184,65 | 1,78% | -4,11% |
|
NasdaqGS:INCY
Incyte
|
57.10 | 104,81% | 153,29% | 12.012,93 | 0% | 27,62% |
|
NasdaqGS:UTHR
United Therapeutics
|
274.26 | -10,71% | -1,33% | 11.803,71 | 0% | 5,22% |
|
NasdaqGS:JAZZ
Jazz Pharmaceuticals
|
108.99 | 53,71% | 67,56% | 7.131,04 | 0% | 5,95% |
|
ENXTPA:SPIE
SPIE
|
37.00 | -8,28% | 0,6% | 6.056,11 | 2,24% | 8,24% |
|
NasdaqGS:EXEL
Exelixis
|
20.91 | 39,15% | 69,39% | 6.338,53 | 0% | -8,84% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
37.31 | -.156,68% | -.149,23% | 5.756,54 | 0% | 0% |
